Influenza as an important factor causing increased risk of patients' deaths, excessive morbidity and prolonged hospital stays.
aged
hospital economics
human influenza
influenza vaccines
length of stay
medical economics
morbidity
mortality
multimorbidity
Journal
Archives of medical science : AMS
ISSN: 1734-1922
Titre abrégé: Arch Med Sci
Pays: Poland
ID NLM: 101258257
Informations de publication
Date de publication:
2023
2023
Historique:
received:
17
06
2020
accepted:
24
05
2021
medline:
4
6
2021
pubmed:
4
6
2021
entrez:
10
8
2023
Statut:
epublish
Résumé
Influenza infection is associated with potential serious complications, increased hospitalization rates and a higher risk of death. A retrospective comparative analysis of selected indicators of hospitalization at the University Hospital in Wroclaw was conducted on patients with confirmed influenza infection and a control group during the 2018-2019 influenza season. The threshold for statistical significance of differences between the groups was set at The types of influenza viruses confirmed in the hospital patients were remarkably similar to those occurring in the general population in Poland. The largest numbers of influenza cases were observed at the departments related to internal medicine where patients with cardiac, lung and renal diseases were hospitalized. The risk of death among the patients with confirmed influenza infection was significantly higher than among the other patients. The highest risk of death was observed among the patients with confirmed influenza infection at the departments related to internal medicine. Considering patients from the entire hospital, the mean length of hospital stay for those with confirmed influenza was 2.13-fold longer than for those in the control group. Comparisons of the median, minimum and maximum lengths of hospitalization between the patients with confirmed influenza infection and the control group reveal even more distinct differences. Significant differences in the selected indicators of hospitalization were observed between the patients with confirmed influenza infection and the control group; they are associated with serious social costs, such as prolonged hospital stay and a higher risk of death during hospitalization in Poland.
Identifiants
pubmed: 37560729
doi: 10.5114/aoms/138145
pii: 138145
pmc: PMC10408030
doi:
Types de publication
Journal Article
Langues
eng
Pagination
941-951Informations de copyright
Copyright: © 2021 Termedia & Banach.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Arch Med Sci. 2013 Oct 31;9(5):854-7
pubmed: 24273569
Aging Clin Exp Res. 2021 Mar;33(3):711-717
pubmed: 31347085
Arch Med Sci. 2019 Sep;15(5):1313-1320
pubmed: 31572479
Arch Med Sci. 2019 Aug 01;16(2):321-336
pubmed: 32190143
Arch Med Sci. 2011 Apr;7(2):345-8
pubmed: 22291779
Arch Med Sci. 2019 Jan 30;16(3):621-626
pubmed: 32399111
Am J Med. 2008 Apr;121(4):258-64
pubmed: 18374680
PLoS One. 2014 Jul 17;9(7):e102634
pubmed: 25032688
Arch Med Sci. 2015 Aug 12;11(4):788-95
pubmed: 26322091
Hum Vaccin Immunother. 2014;10(2):428-40
pubmed: 24165394
Influenza Other Respir Viruses. 2019 Sep;13(5):484-495
pubmed: 31187609
JAMA. 1985 Feb 22;253(8):1136-9
pubmed: 3968844
Arch Med Sci. 2016 Dec 1;12(6):1286-1292
pubmed: 27904520
Int J Epidemiol. 1993 Apr;22(2):334-40
pubmed: 8505193
Scand J Infect Dis. 2011 Sep;43(9):683-9
pubmed: 21604922